IP Library Patent Application 14573017
Patent Application
App. No. 14/573,017

Method and System for Treatment of Biological Tissue

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/573,017
Abstract

A composition for reconstruction, replacement or repair of damaged or diseased biological tissue comprising an extracellular matrix (ECM) composition that includes mesothelial tissue.

Claims (4)

1 . A composition for treating damaged biological tissue, comprising:

an extracellular matrix (ECM) composition comprising acellular mesothelial tissue, wherein, when said ECM composition is administered to said damaged biological tissue, said ECM composition induces bioremodeling and regeneration of new biological tissue.

2 . The composition of claim 1 , wherein said ECM composition further comprises an exogenously added growth factor selected from the group consisting of transforming growth factor beta (TGF-beta), fibroblast growth factor-2 (FGF-2) and vascular epithelial growth factor (VEGF).

3 . The composition of claim 1 , wherein said ECM composition further comprises a fluidizing component selected from the group consisting of water and saline.

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Jun 2, 2017
From: MIDCAP FINANCIAL TRUST
To: CORMATRIX CARDIOVASCULAR, INC.
Reel/Frame 042669/0559 →
SECURITY INTEREST Recorded Sep 30, 2015
From: CORMATRIX CARDIOVASCULAR, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 036732/0103 →